Leukapheresis Market is estimated to be US$ 149.22 by 2022 with a CAGR of 8.7% during the forecast p

Author: Ritvi Kadam

Leukapheresis Market accounted for US$ 64.8 million in 2022 and is estimated to be US$ 149.22 million by 2032 and is anticipated to register a CAGR of 8.7%. Leukapheresis is the procedure used for separating and collecting white blood cells. Leukapheresis is done in patients who are having (AML) acute myeloid leukemia. Leukemia or Hodgkin disease, allergy, tissue damage from burn injury or surgery, rheumatoid arthritis, viral or bacterial infection causes high white blood cell count. High white blood cells causes symptoms like fever, sweat, chilling, decreased appetite and fatigue. High white blood cells causes particular blood cancers. White blood cells which exceed 11,000 micro liter are called leukocytosis. Bone marrow disease causes high production of white blood cells. Fresh leukopaks rich in source of T cells, B cells, and other white blood cells are used in drug development, cell-therapy process development and immunological research. Leukopaks are collected from healthy human donors under IRB approved protocol in FDA registered collection centers. Apheresis machine is used for leukapheresis. Leukapheresis is the treatment that helps in lowering number of leukemia cells in blood temporarily. Leukapheresis is mostly used to collect blood stem cells which are used as a bone marrow transplant in treating blood cancers. Leukapheresis also collects CAR T cells (chimeric antigen receptor) which are certain immune cells in treatment of blood cancers. Leukapheresis are used in extracting all types of white blood cells. Leukapheresis also supports in HIV pathogenesis studies. Compared to chemotherapy Leukapheresis rapidly reduce number of leukocytes and effective method in reducing early mortality of patients having HLL (hyperleukocytic leukaemia). Rising demand of leukopaks and effectiveness in treatment of cancer has given positive impact in growth of Leukapheresis market.

The report "Global Leukapheresis Market, By Type (Leukapheresis Cell Separators, Leukapheresis Columns, Leukapheresis Disposables, Leukoreduction Filters, and Others), By Application (Therapeutic applications, Research applications), By End-Users (Hospitals, Academic and Research Institutes, Biotechnology Industries, Pharmaceutical Industries, Blood Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"

Key Highlights:

  • p>
  • In 2019, PPA research group which is leading supplier of hematologic products in pharmaceutical, biotechnology companies and life science research acquired by BioIVT. These products aid in studies on toxicity assays, drug discovery, target validation and target discovery. With its acquisition, BioIVT has broadened disease state apheresis collections and portfolio of immune cells.
  • In 2020, StemExpress has launched new ‘Frozen Leukopak’ which has offered flexible and convenient time for researchers. The new ‘Frozen Leukopak’ is the product of Leukapheresis obtained from single donor which provides an enriched PBMC (peripheral blood mononuclear cell) fraction which is composed of monocytes and lymphocytes with low red blood cells (RBCs) and granulocytes.

    • Analyst View:

    Leukapheresis has become important and effective procedure in blood cancer treatment and in research study. Leukapheresis corrects metabolic abnormalities and also alleviates the symptoms of leukostasis. In treating hyperleukocytosis leukapheresis has become most important and most imperative adjuvant therapy. Improvements in apparatus of leukapheresis to achieve accurate and rapid sorting of leukocytes and reducing adverse reactions and side effects during procedure is need to be solved. Rising demand of leukopaks in research has fueled the market growth. However, new inventions, advancement in leukopheresis and study on its side effects are highly recommended which can propel the growth of Leukapheresis market till forecast period.

    Before purchasing this report, request a sample or make an inquiry by clicking the following link:

    https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

    Key Market Insights from the report:

    Global Leukapheresis Market accounted for US$ 64.8 million in 2022 and is estimated to be US$ 149.22 million by 2032 and is anticipated to register a CAGR of 8.7%. The Global Leukapheresis Market is segmented based on Type, Application, End-Users and Region.

    • p>
  • Based on Type, Global Leukapheresis Market is segmented into Leukapheresis Cell Separators, Leukapheresis Columns, Leukapheresis Disposables, Leukoreduction Filters, and others.
  • Based on Application, Global Leukapheresis Market is segmented into Therapeutic applications, Research applications.
  • Based on End-Users, Global Leukapheresis Market is segmented into Hospitals, Academic and Research Institutes, Biotechnology Industries, Pharmaceutical Industries, Blood Centers, and others.
  • By Region, the Global Leukapheresis Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

    • Competitive Landscape & their strategies of Global Leukapheresis Market:

    The prominent players operating in the Global Leukapheresis Market includes, Haemonetics Corporation, Asahi Kasei Corporation, Terumo BCT Inc., HemaCare, StemExpress, ZenBio, Macopharma, PPA Research Group, STEMCELL Technologies, Caltag Medsystem, Fresenius, AllCells, BioIVT, and others.

    The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.